Fig. 1From: Molecular characteristics of breast tumors in patients screened for germline predisposition from a population-based observational studyProject outline. Cohort division into clinically relevant breast cancer subgroups and PAM50 molecular subtypes including which information was used to compare the screened and non-screened subpopulations. Patients without ER/HER2 information are not shown in the PAM50 division. Subsets surrounded by dotted lines were not included in the analyses (see Additional file 1: Supplementary Methods)Back to article page